Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Innate Pharma Sa > Profile

Innate Pharma Sa (IPHA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
No. Hedge Fund Shares Value Activity % Port
1.
Millennium Management

Israel Englander

 10,579 $30,468 -12% 0%
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1.
Exchange Traded Concepts, Llc
 46,888 $131,286 0%
2.
Morgan Stanley
 46,354 $129,791 0%
3.
Optiver Holding B.v.
 22,705 $63,574 0%
4.
Rhumbline Advisers
 205 $574 0%
5.
Steward Partners Investment Advisory, Llc
 200 $560 0%
News See All
Innate Pharma S.A. (NASDAQ:IPHA) Q1 2024 Earnings Call Transcript

Innate Pharma S.A. (NASDAQ:IPHA) Q1 2024 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Innate Pharma First Quarter 2024 Financial Results and Business Update Call. All lines have been placed on mute to prevent any background noise.

Keep Reading →

May 15th, 2024 - News Transcripts

Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript

Innate Pharma S.A. (NASDAQ:IPHA) Q4 2023 Earnings Call Transcript

Operator: At this time, I would like to welcome everyone to the Innate Pharma Full Year 2023 Financial Results and Business Update Call.

Keep Reading →

March 22nd, 2024 - News Transcripts

Innate Pharma S.A. (NASDAQ:IPHA) Q3 2023 Earnings Call Transcript

Innate Pharma S.A. (NASDAQ:IPHA) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Innate Pharma Third Quarter 2023 Financial Results and Business Update.

Keep Reading →

November 15th, 2023 - News Transcripts

Innate Pharma S.A. (NASDAQ:IPHA) Q4 2022 Earnings Call Transcript

Innate Pharma S.A. (NASDAQ:IPHA) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. My name is Brent and I will be your conference operator today.

Keep Reading →

March 27th, 2023 - News Transcripts

Innate Pharma S.A. (NASDAQ:IPHA) Q3 2022 Earnings Call Transcript

Operator: Hello, and thank you for standing by. My name is Regina and I will be your conference operator today.

Keep Reading →

December 29th, 2022 - News Transcripts

Is Innate Pharma S.A. (IPHA) A Good Stock To Buy?

Is Innate Pharma S.A. (IPHA) A Good Stock To Buy?

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

May 30th, 2020 - Hedge Funds News

Click here to See All News
Insider Monkey Quarterly Strategy
+275.3% Insider Monkey Quarterly Strategy
+125.2% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through May 20, 2024)